tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GMAB is currently covered by 5 analysts with an average price target of $43.56. This is a potential upside of $6.91 (18.85%) from yesterday's end of day stock price of $36.65.
Genmab AS's activity chart (see below) currently has 192 price targets and 168 ratings on display. The stock rating distribution of GMAB is 95.24% BUY and 4.76% HOLD.
Analysts average stock forecasts to be materialized ratio is 35.34% with an average time for these price targets to be met of 78.38 days.
Highest price target for GMAB is $58, Lowest price target is $38, average price target is $43.56.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT.
Currently out of the existing stock ratings of GMAB, 20 are a BUY (95.24%), 1 are a HOLD (4.76%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Jul-2022
$50
$13.35 (36.43%)
$40
Buy Since 23-Feb-2026
$58
$21.35 (58.25%)
$54
Buy Since 13-Jan-2020
$45
$8.35 (22.78%)
$48
Hold Since 02-May-2022
$43
$6.35 (17.33%)
$32
2 months 16 days ago
(22-Jul-2026)
4/5 (80%)
$14.15 (49.05%)
238
Buy Since 03-Jun-2025
$39
$12.88 (49.31%)
$34
11 months 25 days ago
(13-Oct-2025)
13/14 (92.86%)
$6.32 (19.34%)
123
What is GMAB (Genmab AS) average time for price targets to be met?
Which analyst most recently updated their price target on GMAB (Genmab AS)?
Which analyst has the most public recommendations on GMAB (Genmab AS)?
Which analyst is the currently most bullish on GMAB (Genmab AS)?
Which analyst is the currently most reserved on GMAB (Genmab AS)?
